Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma

Journal Article · · International Journal of Radiation Oncology, Biology and Physics; (USA)
Cancer of the pancreas is most often not diagnosed before it has reached unresectable stages. The development of effective palliative treatment for these patients and for those with recurrence after resection is clearly needed. The present study reports the results of ultrasonically guided percutaneous implantation of {sup 125}I seeds in 19 patients with cancer of the pancreas. Twelve patients had further adjuvant external radiation. Despite satisfactory seed placement and delivery of the planned radiation dose in most cases, clinical improvement was lacking or only slight and short-lived. No difference in survival or palliation was observed between patients treated with seeds alone compared with patients treated with seeds and external radiation. Survival after seed implantation was short (median 140 days, range 7-401 days). Ultrasonically guided percutaneous implantation of {sup 125}I seeds cannot be recommended in the treatment of unresectable carcinoma of the pancreas.
OSTI ID:
6401848
Journal Information:
International Journal of Radiation Oncology, Biology and Physics; (USA), Journal Name: International Journal of Radiation Oncology, Biology and Physics; (USA) Vol. 19:4; ISSN IOBPD; ISSN 0360-3016
Country of Publication:
United States
Language:
English